A journal of the @AmThyroidAssn. Covers the latest clinical #thyroid research & issues. Editor: @DoctorAngell | CT for the Public: @thyroidfriends

Joined October 2018
1,042 Photos and videos
The 2025 @AmThyroidAssn #thyroidcancer guidelines on systemic therapy. Drs. Gild, Brennan, @VenessaTsang review precision careemphasis, molecular profiling, timing & selection of targeted therapy. ow.ly/Hf9y50XVJtO #endotwitter #medtwitter #thyroid #lenvatinib #RET #NTRK
5
15
879
The 2025 @AmThyroidAssn #thyroidcancer guidelines for #TSH suppression: less prescriptive targets & guided by treatment response. Read now by Drs. Mammen, Brenta, and Desai ow.ly/6Hac50XVJqN #endotwitter #medtwitter #thyroid @thancfoundation @Medscape @EndocrineToday
2
6
650
Now online to read. Adding clinical context in ACR-TIRADS alone for #thyroidnodule evaluation may reduce unnecessary #FNA biopsy. Review of study in #JCEM by Drs. Rowe and Croker. ow.ly/F2gO50XVJot #endotwitter #medtwitter #thyroid #ultrasound
3
8
652
What outcomes should be reported after DTC surgery? An international Delphi consensus from Amsterdam establishes an outcome set to standardize selection, reporting in research & practice. ow.ly/Tqhz50XSHT0 @AmThyroidAssn #ThyroidJournal #medtwitter #endotwitter
1
3
5
580
Check out some of the most insightful & content-rich figures that appeared in #ClinicalThyroidology in 2025. ow.ly/1EcE50XVJhA #endotwitter #medtwitter #thyroid
9
18
1,752
Read now online: FT4 immunoassays still vary widely across platforms—recalibration could fix this, w/ more work needed for special populations. Drs. Cubb and Coppola report on data pub’d in @thyroidjournal. ow.ly/3Esg50XVJc9 #endotwitter #medtwitter #TFTs #thyroid
1
2
8
650
Now online to read: A 4-hr post #thyroidectomy #PTH to guide therapy, cuts #hypocalcemia/readmissions, & supports safe same-day discharge when PTH >15 by Chindris et al, reviewed by @DrIramHussain this month. ow.ly/MrK950XVJ5z #endotwitter #medtwitter #thyroid
2
2
9
882
Do all N1b papillary thyroid cancer patients need total thyroidectomy, MRND, and RAI? Multicenter study from Japan compares surgical extent and adjuvant RAI, finding similar survival outcomes across groups. ow.ly/t97C50XSHFb @AmThyroidAssn #ThyroidJournal #medtwitter
2
8
468
Now online: Dr. El-Kawkgi reviews recent findings in @thyroidjournal that pairing #calcitonin w/ #procalcitonin can improve accuracy & cut false positives in detecting MTC. ow.ly/QSHc50XVuQZ @o_kawkgi #endotwitter #medtwitter #thyroidcancer #medullary
1
8
536
The 2025 @AmThyroidAssn #thyroidcancer guidelines: Dr. @Simonedeleo86 & Dr. Pappa look at refined 4 recurrence tiers histology stratification to better guide counseling & treatment. ow.ly/UXix50XTIna #endotwitter #medtwitter @Medscape @EndocrineToday
2
10
663
Do absorbed radioiodine doses predict response in differentiated #thyroidcancer? New @ThyroidJournal UK review finds higher absorbed doses often align better outcomes, but inconsistent dosimetry & follow-up prevent firm dose–response conclusions. ow.ly/a5IR50XSH7y
4
386
Now to read: Dr. @trishacubb reviews data in @thyroidjournal - for select isthmus-confined #PTC, #isthmusectomy matches oncologic outcomes w/ fewer complications & less hormone dependence. ow.ly/WBVy50XVuJU #endotwitter #medtwitter #thyroidcancer #hypothyroidism #thyroid
2
6
587
The 2025 @AmThyroidAssn #thyroidcancer guidelines: Drs. Russell & Kuo consider the recommendations for #lobectomy to achieve oncologic outcomes w/ less morbidity. ow.ly/XSJa50XTIgO #endotwitter #medtwitter @ThyCaInc @Medscape @EndocrineToday @thancfoundation
2
9
766
In the Nov issue for #hyperthyroidism: Dr. Gao reviews meta-analysis data in @thyroidjournal. ATDs dominate as first-line therapy, but #thyroidectomy may lower all-cause and CV mortality. ow.ly/agAF50XTtX1 #methimazole #GravesDisease #thyroid #endotwitter #medtwitter
5
360
It’s December & this month’s issue is here to download & read! Find expert reviews on new clinical #thyroid research. ow.ly/aRuE50XJCMV #endotwitter #medtwitter #thyroidcancer #hypothyroidism #hyperthyroidism @AmThyroidAssn @Medscape @EndocrineToday #GravesDisease
3
342
Still time to read Open Access articles of the October issue. How long is long? Drs. Chris Rowe & Don McLeod detail a study in #JCEM on long-term low dose #methimazole & lower risk of #GravesDisease relapse. ow.ly/1L8g50XvMqC #endotwitter #medtwitter #hyperthyroidism @GDATF
2
9
19
1,944
Still time to read Open Access articles of the October issue. Drs. Omar El-Kawkgi & Shreeyanta review research providing a risk score to predict #thyroid #hormone requirement after #lobectomy. ow.ly/yZ0Y50XvMll #medtwitter #thyroidectomy #levothyroxine #endotwitter
6
11
1,533
Open Access. Review by Dr. Robenshtok on a @MayoClinic study showing the frequency of #thyroid #ultrasound obtained without “appropriate” indications and the associated outcomes. Read it now. ow.ly/8P6c50XvM4X #endotwitter #medtwitter #thyroidnodule
1
7
432
In this issue: Do patients w/ #hyperthyrodism need to be #euthyroid before #thyroidectomy? In Dr. Mammen’s review, understanding new meta-analysis data on the effect of perioperative management suggests similar outcomes. ow.ly/KIUo50XlRlv #endotwitter #medtwitter #thyroid
1
3
8
931